The diagnostics technology developer, backed by Allscripts, Celgene and Blackberry, has filed for an initial public offering provisionally sized at up to $92m.
NantHealth, the personalised healthcare technology offshoot of US-based health technology developer NantWorks that is also backed by several corporates, filed for a $92m initial public offering on Nasdaq on Friday.
NantHealth is developing diagnostics technology that can be tailored for the molecular profile of an individual’s tissues so that medicine can be prescribed more accurately.
The company’s lead product, Clinics, combines software, middleware and hardware systems to gather, organise and analyse billions of molecular, clinical, operational and financial data…
